All Soft Gels, Inc. Announces Raising of $75,000 Initial Capital Need to Launch Full Operations

Company Has Raised the $75,000 It Projected Would be Needed to Begin Full Operations and Ramp Up to Full Production of Product

Salt Lake City, UT, March 08, 2017 --(PR.com)-- All Soft Gels, Inc., a health supplement company, announced that as of January 13, 2017 it has met its goal of raising the initial $75,000 in capital revenues it needed to begin its major operations of producing its soft-gel Kre-Alkalyn Creatine capsule named All Soft Gels Kre-Alkalyn Liquid Gels. The company is now poised to fulfill full operations and to ramp up to full production of the product.

Kre-Alkalyn Creatine is a formula developed unlike regular Creatine, and thus is more easily absorbed into the muscle cells, as capsulated Kre-Alkalyn Creatine has been shown to more effective and economically efficient than creatine monohydrate powders. “All Soft Gels, Inc.’s liquid capsules are easily digestible and allows the consumer to safely consume Creatine to a fuller and more potent level,” explained Mr. Nelson, a world champion bodybuilder who has competed in and won numerous natural bodybuilding shows for more than 33 years, including most recently coming in first place at the 2014 Utah Western Fuel Championship.

“We are extremely excited about reaching our capital revenue goal so quickly,” says CEO Gene Nelson. “With the purchase of a significant amount of liquid creatine last month, the final infusion of capital will allow us to immediately begin to take, and fulfill, orders. It is a major step for our company.”

You can visit the company website at www.allsoftgels.com.

Safe Harbor Disclaimer

This material includes forward-looking statements based on management's Current reasonable business expectations. In this document, the words "can," "anticipates," "believes" and similar expressions identify certain forward-looking statements. These statements are made in reliance on the Private Securities Litigation Reform Act, Section 27A of the Securities Act of 1933, as amended. There are numerous risks and uncertainties that could result in actual results differing materially from expected outcomes. The material should be read in conjunction with the Company's current annual and quarterly reports filed with the SEC, which contain discussions of currently known factors that could significantly impact the Company's future.

Contact:
All Soft Gels, Inc.
Gene Nelson, CEO, (888) 916-5544
Contact
All Soft Gels Inc.
Gene Nelson
888-915-5544
www.allsoftgel.com
ContactContact
Categories